Drug information for CANCIDAS

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; IV (INFUSION) 50MG/VIAL Prescription  (Reference Drug) CASPOFUNGIN ACETATE caspofungin MERCK 21227
2012-05-02 Letter

2010-11-02 Letter

2010-10-25 Label

2010-02-05 Letter

2010-02-04 Label

2009-06-30 Letter

2009-06-29 Label

2009-05-07 Letter

2008-08-13 Label

2008-07-31 Review

2008-07-31 Letter

2008-07-24 Letter

2005-02-17 Letter

2005-02-17 Label

2004-10-04 Letter

2004-10-04 Label

2004-05-28 Letter

2004-04-05 Label

2004-04-05 Label

2004-03-24 Letter

2004-03-24 Letter

2003-03-07 Label

2002-11-21 Label

2002-11-21 Letter

2002-09-20 Label

2002-09-20 Letter

2002-09-20 Label

2002-09-20 Letter

2001-01-26 Review

2001-01-26 Label

2001-01-26 Letter
INJECTABLE; IV (INFUSION) 70MG/VIAL Prescription  (Reference Drug) CASPOFUNGIN ACETATE caspofungin MERCK   "

Drug Adverse Effects information for CANCIDAS

Role code Indications Reaction # Reports
PS ACUTE MYELOID LEUKAEMIA DRUG INEFFECTIVE 3
PS ACUTE MYELOID LEUKAEMIA VENOOCCLUSIVE LIVER DISEASE 3
PS ANALGESIC THERAPY CANDIDA PNEUMONIA 4
PS ANALGESIC THERAPY TREATMENT FAILURE 2
PS ANTIFUNGAL TREATMENT DRUG INEFFECTIVE 2
PS ANTIFUNGAL TREATMENT VENOOCCLUSIVE LIVER DISEASE 1
PS ANTIFUNGAL TREATMENT ZYGOMYCOSIS 1
PS ASPERGILLOSIS CARDIOPULMONARY FAILURE 1
PS ASPERGILLOSIS PNEUMONIA ASPIRATION 1
PS BLOOD CULTURE POSITIVE DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS BLOOD CULTURE POSITIVE MULTI-ORGAN FAILURE 1
PS BRONCHOPULMONARY ASPERGILLOSIS DRUG INEFFECTIVE 5
PS BRONCHOPULMONARY ASPERGILLOSIS HYPOKALAEMIA 2
PS BRONCHOPULMONARY ASPERGILLOSIS HYPOTENSION 2
PS BRONCHOPULMONARY ASPERGILLOSIS RESPIRATORY ARREST 2
PS BRONCHOPULMONARY ASPERGILLOSIS SEPTIC SHOCK 2
PS BRONCHOPULMONARY ASPERGILLOSIS SHOCK 1
PS BRONCHOPULMONARY ASPERGILLOSIS ZYGOMYCOSIS 1
PS CANDIDA SEPSIS ACUTE HEPATIC FAILURE 2
PS CANDIDA SEPSIS HAEMATOMA INFECTION 2
PS CANDIDA SEPSIS ILEUS PARALYTIC 2
PS CANDIDA SEPSIS LIVER INJURY 2
PS CANDIDIASIS CANDIDA PNEUMONIA 4
PS CANDIDIASIS CHOLESTASIS 1
PS CANDIDIASIS DEEP VEIN THROMBOSIS 1
PS CANDIDIASIS DEVICE RELATED INFECTION 1
PS CANDIDIASIS DRUG INEFFECTIVE 1
PS CANDIDIASIS DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS CANDIDIASIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
PS CANDIDIASIS MEDICATION ERROR 1
PS CANDIDIASIS MULTI-ORGAN FAILURE 1
PS CANDIDIASIS THROMBOTIC MICROANGIOPATHY 1
PS CANDIDIASIS TREATMENT FAILURE 2
PS CONVULSION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS CONVULSION MULTI-ORGAN FAILURE 1
PS EPILEPSY CHOLESTASIS 3
PS EPILEPSY DEVICE RELATED INFECTION 3
PS EPILEPSY GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
PS EVIDENCE BASED TREATMENT ABDOMINAL COMPARTMENT SYNDROME 1
PS EVIDENCE BASED TREATMENT DEATH 1
PS EVIDENCE BASED TREATMENT DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS EVIDENCE BASED TREATMENT FUNGAL INFECTION 1
PS EVIDENCE BASED TREATMENT MULTI-ORGAN FAILURE 1
PS EVIDENCE BASED TREATMENT PATHOGEN RESISTANCE 1
PS EVIDENCE BASED TREATMENT RELAPSING FEVER 1
PS FEBRILE NEUTROPENIA HEPATOTOXICITY 5
PS FEBRILE NEUTROPENIA TRANSAMINASES INCREASED 5
PS FUNGAL INFECTION BLOOD PRESSURE DECREASED 1
PS FUNGAL INFECTION DEATH 3
PS FUNGAL INFECTION DRUG INEFFECTIVE 2
PS FUNGAL INFECTION HEART RATE DECREASED 1
PS FUNGAL INFECTION HEPATIC ENZYME INCREASED 1
PS FUNGAL INFECTION MULTI-ORGAN FAILURE 1
PS FUNGAL INFECTION OFF LABEL USE 4
PS FUNGAL INFECTION RESPIRATORY ARREST 4
PS FUNGAL INFECTION RESPIRATORY RATE DECREASED 4
PS FUNGAL INFECTION SEPTIC SHOCK 2
PS FUNGAL INFECTION VOMITING 1
PS GRAFT VERSUS HOST DISEASE DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS GRAFT VERSUS HOST DISEASE MULTI-ORGAN FAILURE 1
PS HAEMATURIA HYPOKALAEMIA 1
PS HAEMATURIA HYPOTENSION 1
PS HAEMATURIA RESPIRATORY ARREST 1
PS INSOMNIA HYPOKALAEMIA 1
PS INSOMNIA HYPOTENSION 1
PS INSOMNIA RESPIRATORY ARREST 1
PS ORAL CANDIDIASIS HEPATIC ENZYME INCREASED 1
PS ORAL CANDIDIASIS MULTI-ORGAN FAILURE 1
PS PAIN HYPOKALAEMIA 1
PS PAIN HYPOTENSION 1
PS PAIN RESPIRATORY ARREST 1
PS PNEUMONIA FUNGAL BLOOD CREATINE PHOSPHOKINASE INCREASED 1
PS PNEUMONIA FUNGAL OVERDOSE 1
PS PNEUMONIA FUNGAL RHABDOMYOLYSIS 1
PS POSTOPERATIVE WOUND INFECTION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4
PS POSTOPERATIVE WOUND INFECTION MULTI-ORGAN FAILURE 4
PS PROCEDURAL PAIN DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
PS PROCEDURAL PAIN MULTI-ORGAN FAILURE 3
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 4
PS PRODUCT USED FOR UNKNOWN INDICATION TRANSAMINASES INCREASED 4
PS PYREXIA VENOOCCLUSIVE LIVER DISEASE 2
PS RESPIRATORY TRACT INFECTION DRUG INEFFECTIVE 4
PS SEPSIS CHOLESTASIS 1
PS SEPSIS DEVICE RELATED INFECTION 1
PS SEPSIS DRUG INEFFECTIVE 1
PS SEPSIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
PS SEPSIS MEDICATION ERROR 1
PS SEPTIC SHOCK HEPATIC ENZYME INCREASED 2
PS SEPTIC SHOCK MULTI-ORGAN FAILURE 2
PS SEPTIC SHOCK PANCREATITIS ACUTE 4
PS SYSTEMIC CANDIDA DRUG INEFFECTIVE 4
PS SYSTEMIC CANDIDA SEPTIC SHOCK 4
PS VASCULITIS PANCREATITIS ACUTE 2
SS ABDOMINAL SEPSIS DERMATITIS EXFOLIATIVE 5
SS ABDOMINAL SEPSIS URTICARIA 5
SS ACUTE MYELOID LEUKAEMIA VENOOCCLUSIVE LIVER DISEASE 3
SS ANTIFUNGAL TREATMENT DRUG INEFFECTIVE 6
SS ANTIFUNGAL TREATMENT VENOOCCLUSIVE LIVER DISEASE 1
SS ANTIFUNGAL TREATMENT ZYGOMYCOSIS 3
SS BLOOD CULTURE POSITIVE DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
SS BLOOD CULTURE POSITIVE MULTI-ORGAN FAILURE 1
SS BRONCHOPULMONARY ASPERGILLOSIS DRUG INEFFECTIVE 6
SS BRONCHOPULMONARY ASPERGILLOSIS HYPOKALAEMIA 7
SS BRONCHOPULMONARY ASPERGILLOSIS HYPOTENSION 2
SS BRONCHOPULMONARY ASPERGILLOSIS RESPIRATORY ARREST 2
SS BRONCHOPULMONARY ASPERGILLOSIS ZYGOMYCOSIS 3
SS CANDIDIASIS CHOLESTASIS 3
SS CANDIDIASIS DEVICE RELATED INFECTION 3
SS CANDIDIASIS DRUG INEFFECTIVE 1
SS CANDIDIASIS DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
SS CANDIDIASIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
SS CANDIDIASIS MEDICATION ERROR 1
SS CANDIDIASIS MULTI-ORGAN FAILURE 1
SS CONVULSION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
SS CONVULSION MULTI-ORGAN FAILURE 1
SS EPILEPSY CHOLESTASIS 9
SS EPILEPSY DEVICE RELATED INFECTION 9
SS EPILEPSY GAMMA-GLUTAMYLTRANSFERASE INCREASED 9
SS EVIDENCE BASED TREATMENT DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
SS EVIDENCE BASED TREATMENT MULTI-ORGAN FAILURE 1
SS FEBRILE NEUTROPENIA HEPATOTOXICITY 1
SS FEBRILE NEUTROPENIA TRANSAMINASES INCREASED 1
SS FUNGAL INFECTION DEATH 2
SS FUNGAL INFECTION HEPATIC ENZYME INCREASED 3
SS FUNGAL INFECTION MULTI-ORGAN FAILURE 3
SS FUNGAL INFECTION OFF LABEL USE 4
SS FUNGAL INFECTION RESPIRATORY ARREST 4
SS FUNGAL INFECTION RESPIRATORY RATE DECREASED 4
SS GRAFT VERSUS HOST DISEASE DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
SS GRAFT VERSUS HOST DISEASE MULTI-ORGAN FAILURE 1
SS HAEMATURIA HYPOKALAEMIA 1
SS HAEMATURIA HYPOTENSION 1
SS HAEMATURIA RESPIRATORY ARREST 1
SS HYPOTHYROIDISM DERMATITIS EXFOLIATIVE 1
SS HYPOTHYROIDISM URTICARIA 1
SS INSOMNIA HYPOKALAEMIA 1
SS INSOMNIA HYPOTENSION 1
SS INSOMNIA RESPIRATORY ARREST 1
SS ORAL CANDIDIASIS HEPATIC ENZYME INCREASED 3
SS ORAL CANDIDIASIS MULTI-ORGAN FAILURE 3
SS PAIN HYPOKALAEMIA 1
SS PAIN HYPOTENSION 1
SS PAIN RESPIRATORY ARREST 1
SS POSTOPERATIVE WOUND INFECTION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4
SS POSTOPERATIVE WOUND INFECTION MULTI-ORGAN FAILURE 4
SS PROCEDURAL PAIN DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
SS PROCEDURAL PAIN MULTI-ORGAN FAILURE 3
SS PYREXIA VENOOCCLUSIVE LIVER DISEASE 2
SS SEDATION HYPOKALAEMIA 1
SS SEPSIS CHOLESTASIS 3
SS SEPSIS DEVICE RELATED INFECTION 3
SS SEPSIS DRUG INEFFECTIVE 1
SS SEPSIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
SS SEPSIS MEDICATION ERROR 1
SS SEPTIC SHOCK HEPATIC ENZYME INCREASED 6
SS SEPTIC SHOCK MULTI-ORGAN FAILURE 6
C ASPERGILLOSIS CHOLESTASIS 1
C ASPERGILLOSIS JAUNDICE 1
C ATRIAL FIBRILLATION CARDIAC ARREST 2
C ATRIAL FIBRILLATION DRUG INTERACTION 2
C ATRIAL FIBRILLATION HYPOTENSION 2
C CANDIDIASIS ACUTE RESPIRATORY DISTRESS SYNDROME 2
C CANDIDIASIS CYTOLYTIC HEPATITIS 2
C CANDIDIASIS DIARRHOEA 2
C CANDIDIASIS HAEMORRHAGE 2
C CANDIDIASIS HEPATIC FUNCTION ABNORMAL 2
C CANDIDIASIS PANCYTOPENIA 6
C CANDIDIASIS SEPTIC SHOCK 2
C CROHN'S DISEASE ACUTE RESPIRATORY DISTRESS SYNDROME 2
C CROHN'S DISEASE CYTOLYTIC HEPATITIS 2
C CROHN'S DISEASE DIARRHOEA 2
C CROHN'S DISEASE HAEMORRHAGE 2
C CROHN'S DISEASE HEPATIC FUNCTION ABNORMAL 2
C CROHN'S DISEASE PANCYTOPENIA 6
C CROHN'S DISEASE SEPTIC SHOCK 2
C CYTOMEGALOVIRUS INFECTION ACUTE RESPIRATORY DISTRESS SYNDROME 4
C CYTOMEGALOVIRUS INFECTION CYTOLYTIC HEPATITIS 4
C CYTOMEGALOVIRUS INFECTION DIARRHOEA 4
C CYTOMEGALOVIRUS INFECTION HAEMORRHAGE 4
C CYTOMEGALOVIRUS INFECTION HEPATIC FUNCTION ABNORMAL 4
C CYTOMEGALOVIRUS INFECTION PANCYTOPENIA 12
C CYTOMEGALOVIRUS INFECTION SEPTIC SHOCK 4
C DENTAL DISORDER PROPHYLAXIS ACUTE ABDOMEN 1
C DENTAL DISORDER PROPHYLAXIS ANASTOMOTIC LEAK 1
C DENTAL DISORDER PROPHYLAXIS BURKHOLDERIA TEST POSITIVE 1
C DENTAL DISORDER PROPHYLAXIS LEUKOCYTOSIS 1
C DENTAL DISORDER PROPHYLAXIS LUNG INFILTRATION 1
C DENTAL DISORDER PROPHYLAXIS PRODUCT CONTAMINATION 1
C DENTAL DISORDER PROPHYLAXIS PYREXIA 1
C DENTAL DISORDER PROPHYLAXIS RESPIRATORY FAILURE 1
C EVIDENCE BASED TREATMENT CARDIAC ARREST 1
C EVIDENCE BASED TREATMENT DRUG INTERACTION 1
C EVIDENCE BASED TREATMENT HYPOTENSION 1
C FEBRILE CONVULSION PANCYTOPENIA 8
C FUNGAEMIA CARDIAC ARREST 1
C FUNGAEMIA DRUG INTERACTION 1
C FUNGAEMIA HYPOTENSION 1
C HEART RATE ABNORMAL CARDIAC ARREST 2
C HEART RATE ABNORMAL DRUG INTERACTION 2
C HEART RATE ABNORMAL HYPOTENSION 2
C HEART RATE INCREASED CARDIAC ARREST 2
C HEART RATE INCREASED DRUG INTERACTION 2
C HEART RATE INCREASED HYPOTENSION 2
C LUNG INFECTION HYPOGLYCAEMIA 1
C LUNG INFECTION HYPOTENSION 1
C LUNG TRANSPLANT CHOLESTASIS 2
C LUNG TRANSPLANT JAUNDICE 2
C PNEUMONIA ACUTE ABDOMEN 1
C PNEUMONIA ANASTOMOTIC LEAK 1
C PNEUMONIA BURKHOLDERIA TEST POSITIVE 1
C PNEUMONIA LEUKOCYTOSIS 1
C PNEUMONIA LUNG INFILTRATION 1
C PNEUMONIA PRODUCT CONTAMINATION 1
C PNEUMONIA PYREXIA 1
C PNEUMONIA RESPIRATORY FAILURE 1
C PROPHYLAXIS ACUTE ABDOMEN 1
C PROPHYLAXIS ANASTOMOTIC LEAK 1
C PROPHYLAXIS BURKHOLDERIA TEST POSITIVE 1
C PROPHYLAXIS LEUKOCYTOSIS 1
C PROPHYLAXIS LUNG INFILTRATION 1
C PROPHYLAXIS PRODUCT CONTAMINATION 1
C PROPHYLAXIS PYREXIA 1
C PROPHYLAXIS RESPIRATORY FAILURE 1
C PULMONARY TUBERCULOSIS CHOLESTASIS 2
C PULMONARY TUBERCULOSIS JAUNDICE 2
C PYREXIA ACUTE RESPIRATORY DISTRESS SYNDROME 8
C PYREXIA CYTOLYTIC HEPATITIS 8
C PYREXIA DIARRHOEA 8
C PYREXIA HAEMORRHAGE 8
C PYREXIA HEPATIC FUNCTION ABNORMAL 8
C PYREXIA PANCYTOPENIA 16
C PYREXIA SEPTIC SHOCK 8
C SEPSIS CONDITION AGGRAVATED 1
C SEPSIS PATHOGEN RESISTANCE 1
C STEM CELL TRANSPLANT BLOOD CREATININE INCREASED 1
C STEM CELL TRANSPLANT BLOOD LACTATE DEHYDROGENASE INCREASED 1
C STEM CELL TRANSPLANT BLOOD UREA INCREASED 1
C STEM CELL TRANSPLANT BONE MARROW FAILURE 1
C STEM CELL TRANSPLANT HAPTOGLOBIN DECREASED 1
C STEM CELL TRANSPLANT PLATELET COUNT DECREASED 1
C STEM CELL TRANSPLANT THROMBOTIC MICROANGIOPATHY 1
C SYSTEMIC CANDIDA CARDIAC ARREST 1
C SYSTEMIC CANDIDA DRUG INTERACTION 1
C SYSTEMIC CANDIDA HYPOTENSION 1
I ASPERGILLOSIS DRUG INTERACTION 2
I ASPERGILLOSIS DRUG LEVEL INCREASED 2
I ASPERGILLOSIS RENAL FAILURE ACUTE 2
I LUNG TRANSPLANT DRUG INTERACTION 2
I LUNG TRANSPLANT DRUG LEVEL INCREASED 2
I LUNG TRANSPLANT RENAL FAILURE ACUTE 2
I OPPORTUNISTIC INFECTION PROPHYLAXIS DRUG INTERACTION 1
I OPPORTUNISTIC INFECTION PROPHYLAXIS DRUG LEVEL INCREASED 1
I OPPORTUNISTIC INFECTION PROPHYLAXIS RENAL FAILURE ACUTE 1
I TUBERCULOSIS DRUG INTERACTION 2
I TUBERCULOSIS DRUG LEVEL INCREASED 2
I TUBERCULOSIS RENAL FAILURE ACUTE 2
Ads by Google